The Good, the Bad, and the Best Jobs - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Good, the Bad, and the Best Jobs
Readers provide insight into the best companies to work for as well as the ups and downs of their jobs.

Pharmaceutical Technology
Volume 32, Issue 12, pp. 74-73

Worst aspects of jobs

"Lack of acknowledgment by management of my role."

"Constraints of compliance to change."

"Constant state of not knowing how long we will be employed."

"No rewards for going the extra mile," ... "or for discovery."

"Continuously changing internal requirements."

"High work load as many projects are pushed through the pipeline."

"Turnover" ... "and frequent reorganization."

"Waiting for results from universities."

"A dull and redundant work/repeat" and "shift work."

"No appreciation that we're running a global business and need global processes."

"Regulations, regulations, regulations."

"Lulls in the work cycle."

"Having to contract to people who think they know all the answers."

"Regular panic to meet customer deadlines."

"Management does not listen to or adapt new creative ideas."

"I'm stuck in a deadbeat town somewhere in Germany."

"No improvement in quality of products."

"Working across different time zones."

"Frustrations of failed experiments."

"It's hard to see how my daily activities are advancing the larger strategy."

"Slow computer systems," and "old, unreliable equipment."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here